articleTop 10% cited

Development and Characterization of Gemcitabine-Resistant Pancreatic Tumor Cells

Annals of Surgical Oncology · 2007 · Vol. 14(12) · pp. 3629–3637

Ami N. Shah✉(The University of Texas MD Anderson Cancer Center)Justin M. Summy(The University of Texas MD Anderson Cancer Center)Jing Zhang(The University of Texas MD Anderson Cancer Center)Serk In Park(The University of Texas MD Anderson Cancer Center)Nila U. Parikh(The University of Texas MD Anderson Cancer Center)Gary E. Gallick(The University of Texas MD Anderson Cancer Center)

View via DOI Publisher page

Cancer Cells and Metastasis Pancreatic and Hepatic Oncology Research Liver physiology and pathologyGemcitabinePancreatic cancerCancer researchCD44Epithelial–mesenchymal transitionVimentinCancer stem cellBiologyPathologyStem cell

MeSH terms

GemcitabineAntimetabolites, AntineoplasticCell AdhesionCell MovementDeoxycytidineEpitheliumFlow CytometryHumansMembrane ProteinsMesodermNeoplasm InvasivenessPancreatic NeoplasmsTumor Cells, CulturedImmunoblottingCadherins

Citations

432

FWCI

9.76

field-weighted impact

References

Percentile

99%

vs. same field & year

Citations per year

Cited by

The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs